-+ 0.00%
-+ 0.00%
-+ 0.00%

FORMOSA PHARMACEUTICALS ANNOUNCES LICENSING AGREEMENT WITH RXILIENT, FOR COMMERCIALIZATION OF CLOBETASOL PROPIONATE OPHTHALMIC SUSPENSION FOR THE TREATMENT OF INFLAMMATION AND PAIN FOLLOWING OCULAR SURGERY

Reuters·12/03/2025 10:00:00

Please log in to view news